NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26
NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26  
Podcast: Mad Money w/ Jim Cramer
Published On: Fri Nov 13 2026
Description: November 12, 2026; start time unavailable: Jim Cramer weighs what a Jensen-less NVIDIA could mean for shareholders, breaks down Kraft Heinz’s turnaround pitch and Anthropic’s IPO setup, and interviews Moderna CEO Stéphane Bancel about the company’s cancer vaccine pipeline.Mad Money Disclaimer  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.